Biogen Lowers FY2026 Adj EPS Guidance from $14.25-$15.25 to $12.00-$13.00 vs $12.83 Est
Biogen (NASDAQ:BIIB) lowers FY2026 Adj EPS guidance from $14.25-$15.25 to $12.00-$13.00 vs $12.83 analyst estimate..
Biogen said it will earn less money per share next year than it promised before—about 12 to 13 dollars instead of 14 to 15 dollars. When a company lowers its forecast, it hints that business might be tougher ahead, so it's worth watching how the company explains why.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.